Literature DB >> 8557344

Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.

F R Noriega1, G Losonsky, J Y Wang, S B Formal, M M Levine.   

Abstract

The use of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a live vector for enterotoxigenic Escherichia coli (ETEC) antigens is reported. CVD 1203 alone or expressing colonization factor antigen fimbriae and CS3 fibrillae of ETEC was given to guinea pigs and mice, orogastrically (o.g.) or intranasally (i.n.). CVD 1203 given i.n. elicited high titers of antilipopolysaccharide (anti-LPS) immunoglobulin A (IgA) and was protective in guinea pigs against a homologous conjunctival challenge. Whereas a strong IgA response against colonization factor antigen CS3, and Shigella LPS was detected in tears and serum of guinea pigs after o.g. or i.n. immunization, the i.n. route elicited significantly higher antibody titers. A strong serum IgG response was also observed against the ETEC antigens, although no serum anti-LPS IgG response was detected. The immune response in mice followed a pattern similar to that in guinea pigs, and the difference between the responses after o.g. and i.n. administration was even more remarkable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557344      PMCID: PMC173722          DOI: 10.1128/iai.64.1.23-27.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  [Not Available].

Authors:  B SERENY
Journal:  Acta Microbiol Acad Sci Hung       Date:  1957

2.  Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by delta aroC, delta aroD Salmonella typhi vaccine strain CVD 908.

Authors:  J A Girón; J G Xu; C R González; D Hone; J B Kaper; M M Levine
Journal:  Vaccine       Date:  1995-07       Impact factor: 3.641

3.  Immunity to enterotoxigenic Escherichia coli.

Authors:  M M Levine; D R Nalin; D L Hoover; E J Bergquist; R B Hornick; C R Young
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

Review 4.  Advances in influenza virus vaccine research.

Authors:  R B Couch
Journal:  Ann N Y Acad Sci       Date:  1993-06-23       Impact factor: 5.691

5.  Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi.

Authors:  S Langermann; S Palaszynski; A Sadziene; C K Stover; S Koenig
Journal:  Nature       Date:  1994-12-08       Impact factor: 49.962

6.  Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.

Authors:  F R Noriega; J Y Wang; G Losonsky; D R Maneval; D M Hone; M M Levine
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

7.  Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.

Authors:  M M Levine; E J Bergquist; D R Nalin; D H Waterman; R B Hornick; C R Young; S Sotman
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

8.  Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.

Authors:  K L Kotloff; G A Losonsky; J P Nataro; S S Wasserman; T L Hale; D N Taylor; J W Newland; J C Sadoff; S B Formal; M M Levine
Journal:  Vaccine       Date:  1995-04       Impact factor: 3.641

9.  Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.

Authors:  N Orr; G Robin; D Cohen; R Arnon; G H Lowell
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

Review 10.  Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.

Authors:  M M Levine
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

View more
  20 in total

Review 1.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.

Authors:  J Y Wang; M F Pasetti; F R Noriega; R J Anderson; S S Wasserman; J E Galen; M B Sztein; M M Levine
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor.

Authors:  Nancy Walters; Theresa Trunkle; Michael Sura; David W Pascual
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Establishment of unipolar localization of IcsA in Shigella flexneri 2a is not dependent on virulence plasmid determinants.

Authors:  R C Sandlin; A T Maurelli
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  Parameters underlying successful protection with live attenuated mutants in experimental shigellosis.

Authors:  M L Bernardini; J Arondel; I Martini; A Aidara; P J Sansonetti
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.

Authors:  G A Losonsky; Y Lim; P Motamedi; L E Comstock; J A Johnson; J G Morris; C O Tacket; J B Kaper; M M Levine
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

7.  Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.

Authors:  K L Kotloff; F Noriega; G A Losonsky; M B Sztein; S S Wasserman; J P Nataro; M M Levine
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

8.  Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.

Authors:  Z Altboum; E M Barry; G Losonsky; J E Galen; M M Levine
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

9.  Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.

Authors:  Tao Wu; Christen Grassel; Myron M Levine; Eileen M Barry
Journal:  Infect Immun       Date:  2011-10-03       Impact factor: 3.441

10.  Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants.

Authors:  Antonella Cersini; Maria Celeste Martino; Irene Martini; Giacomo Rossi; Maria Lina Bernardini
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.